Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Werner

Showing results (191-200 of 593) with videos related to

Pageof 60
Sort By:
Journal of Biomedical Materials Research|January 1, 1979
Direct anchorage of Al2O3-ceramic hip components: three years of clinical experience and results of further animal studiesG Heimke, P Griss, G Jentschura, et al.
British Journal of Pharmacology|July 2, 2011
Amplified NO/cGMP-mediated relaxation and ryanodine receptor-to-BKCa channel signalling in corpus cavernosum smooth muscle from phospholamban knockout miceShreena Joshi, Mark T Nelson, Matthias E Werner
Analytical Biochemistry|May 15, 1996
Effect of polybrene on the N-terminal sequencing of peptides bound to polyvinylidene difluoride membranesW E Werner, C Grimley, P M Yuan
The British Journal of Ophthalmology|November 26, 1998
Acute effect of metipranolol on the retinal circulationS Wolf, E Werner, K Schulte, et al.
Die Pharmazie|April 1, 1985
[The pharmacokinetics of rifampicin in the intermittent treatment of patients with pulmonary tuberculosis. 2. The effect of rifampicin on the course of therapy for mycobacteriosis and non-tubercular infectious diseases]H Eule, E Werner, K Winsel, et al.
Journal of Pharmacological and Toxicological Methods|December 17, 2013
A quantitative bifunctional in vitro potency assay for botulinum neurotoxin serotype ARichard W Gregory, William E Werner, Curtis Ruegg
Tubercle|March 1, 1974
Intermittent chemotherapy of pulmonary tuberculosis using rifampicin and isoniazid for primary treatment: the influence of various factors on the frequency of side-effectsH Eule, E Werner, K Winsel, et al.
The American Journal of Clinical Nutrition|June 5, 1999
Limited effect of refined carbohydrate dietary supplementation on colonization of the gastrointestinal tract of healthy subjects by Candida albicansM Weig, E Werner, M Frosch, et al.
Scandinavian Journal of Respiratory Diseases|January 1, 1976
On the pharmacokinetics of rifampicin during treatment with intermittent administration. II. Influence of age and sex and of the patientsH Iwainsky, K Winsel, E Werner, et al.
Klinische Wochenschrift|February 17, 1986
[Cryptococcus neoformans meningoencephalitis in AIDS]C Bohle, M Sinn, E Werner, et al.
Pageof 60

Showing results (191-200 of 593) with videos related to

Sort By:
Pageof 60
Journal of Biomedical Materials Research|January 1, 1979
Direct anchorage of Al2O3-ceramic hip components: three years of clinical experience and results of further animal studiesG Heimke, P Griss, G Jentschura, et al.
British Journal of Pharmacology|July 2, 2011
Amplified NO/cGMP-mediated relaxation and ryanodine receptor-to-BKCa channel signalling in corpus cavernosum smooth muscle from phospholamban knockout miceShreena Joshi, Mark T Nelson, Matthias E Werner
Analytical Biochemistry|May 15, 1996
Effect of polybrene on the N-terminal sequencing of peptides bound to polyvinylidene difluoride membranesW E Werner, C Grimley, P M Yuan
The British Journal of Ophthalmology|November 26, 1998
Acute effect of metipranolol on the retinal circulationS Wolf, E Werner, K Schulte, et al.
Die Pharmazie|April 1, 1985
[The pharmacokinetics of rifampicin in the intermittent treatment of patients with pulmonary tuberculosis. 2. The effect of rifampicin on the course of therapy for mycobacteriosis and non-tubercular infectious diseases]H Eule, E Werner, K Winsel, et al.
Journal of Pharmacological and Toxicological Methods|December 17, 2013
A quantitative bifunctional in vitro potency assay for botulinum neurotoxin serotype ARichard W Gregory, William E Werner, Curtis Ruegg
Tubercle|March 1, 1974
Intermittent chemotherapy of pulmonary tuberculosis using rifampicin and isoniazid for primary treatment: the influence of various factors on the frequency of side-effectsH Eule, E Werner, K Winsel, et al.
The American Journal of Clinical Nutrition|June 5, 1999
Limited effect of refined carbohydrate dietary supplementation on colonization of the gastrointestinal tract of healthy subjects by Candida albicansM Weig, E Werner, M Frosch, et al.
Scandinavian Journal of Respiratory Diseases|January 1, 1976
On the pharmacokinetics of rifampicin during treatment with intermittent administration. II. Influence of age and sex and of the patientsH Iwainsky, K Winsel, E Werner, et al.
Klinische Wochenschrift|February 17, 1986
[Cryptococcus neoformans meningoencephalitis in AIDS]C Bohle, M Sinn, E Werner, et al.
Pageof 60